Uniting Against Lung Cancer Reaches New Funding Heights, Awarding Over $1.5 Million in Lung Cancer Research Grants

By The Associated Press | Posted - Apr 25th, 2014 @ 6:41am





Uniting Against Lung Cancer Reaches New Funding Heights, Awarding Over

$1.5 Million in Lung Cancer Research Grants

NEW YORK, April 25, 2014 /PRNewswire/ -- Uniting Against Lung Cancer

(UALC), a nonprofit dedicated to funding innovative research and

raising awareness for lung cancer, announces that it has achieved a

new level of funding this year, committing more than $1.5 million in

lung cancer research grants to premier medical and research

institutions across the country. This contribution brings UALC's total

funding for lung cancer research grants to a total of $11.5 million.

Lung cancer is the nation's deadliest cancer, responsible for over

220,000 new diagnoses and nearly 160,000 cancer deaths each year. With

the support of its partners across the country, UALC funds the

critical research that will improve treatment options, extend

survival, and find a cure for lung cancer patients. These efforts have

led to more than $55 million in continued support from federal and

public sources, new therapies in clinical trials, and major advances

improving treatment for thousands of lung cancer patients.

Recipients of funding are selected by the UALC Medical Committee,

comprised of the top physicians and scientists in the field. This

year's grantees are developing new methods for early detection of lung

cancer; investigating new targets and novel therapies for both small

cell and non small cell lung cancer; and gaining a greater

understanding of the origins of lung cancer to find a cure for the

nation's leading cancer killer.

New funding opportunities will be open to applicants in May 2014.

Visit http://www.unitingagainstlungcancer.org/research for more


Recipients of UALC funding are:

Collin Blakely, MD, PhD University of California, San Francisco

Evolution and impact of tumor molecular heterogeneity on response to

EGFR-targeted lung cancer therapy Sponsored by Uniting Against Lung

Cancer and Free to Breathe

Emily Cheng, MD, PhD Memorial Sloan-Kettering Cancer Center Targeting

the BCL-2 Family in Small Cell Lung Cancer Sponsored by The Judy &

Fred Wilpon Foundation and Tishman Speyer

William Cheung, PhD Yale University Treating metastasis by

differentiation therapy: Identifying druggable pathways Sponsored by

The Tom Zangas Lung Cancer Foundation and the Mike Pascucci Lung

Cancer Association

Curtis Chong, MD, PhD Dana-Farber Cancer Institute Combination

screening of targeted therapies as a strategy to understand and

overcome resistance to EGFR inhibitors in lung cancer patients

Sponsored by the Marjorie M. Fisher Fund, the Tighe-Hidalgo

Foundation, and the Office of Dr. David Hidalgo

Subhajyoti De, PhD University of Colorado, Denver Identifying

potential driver mutations in gene promoters in a cohort of completely

sequenced NSCLC genomes Sponsored by Elliot's Legacy and Joan's Legacy

Anna Farago, MD, PhD Massachusetts General Hospital Cancer Center

Leveraging genetically engineered preclinical models of small cell

lung cancer for advanced therapeutic studies Sponsored by Elliot's

Legacy and Joan's Legacy

Christine Fillmore, PhD Children's Hospital Boston Epigenetic

inhibitors in personalized therapy for Brg1 and EGFR mutant lung

tumors Sponsored by Joan's Legacy in honor of Meryl Bralower

Zeynep Gumus, PhD Weill Cornell Medical College Identification of

Constitutional Risk Genes for Non-Small Cell Lung Cancer

Adenocarcinoma Sponsored by The Ira Waldbaum Family Foundation and The

Malinsky Family Charitable Trust

Sandra Hofmann, PhD University of Texas Southwestern Medical Center

DHHC Protein Palmitoyltransferases in Small Cell Lung Cancer Sponsored

by Elliot's Legacy and Joan's Legacy

Matthew Niederst, PhD Massachusetts General Hospital Cancer Center

Determining the mechanisms of intrinsic and acquired resistance to the

3rd generation EGFR inhibitor CO-1686 Sponsored by Pershing Square

Capital Management and Joan's Legacy

Ann Marie Pendergast, PhD Duke University Medical Center Novel

druggable pathway required for lung cancer progression and metastasis

Sponsored by The Hank Thompson Fund, Lily's Light, and the Caine

Halter Fund for Lung Cancer Research

David Shackelford, MD, PhD University of California, Los Angeles

Targeting LKB1-deficient non-small cell lung cancer through the NRF2

pathway Sponsored by Greenlight Capital and The Durst Organization

Takeshi Shimamura, PhD Loyola University Chicago BET bromodomain

inhibitor resistance in LKB1 deficient mutant KRAS NSCLC Sponsored by

Chicago Lung Run

Ferdinandos Skoulidis, MD, PhD MD Anderson Cancer Center Impact of NF1

inactivation on the pathogenesis, signaling circuitry and therapeutic

responsiveness of NSCLC in a novel co-clinical trial of targeted

therapy Sponsored by Elliot's Legacy and Joan's Legacy

Alison Taylor, PhD Dana-Farber Cancer Institute Chromosomal Gains in

Lung Squamous Carcinoma Sponsored by the Nancy Raisman Memorial Fund

To see a complete description of the funded projects and to learn more

about supporting UALC Scientific Programs, visit


About Uniting Against Lung Cancer Uniting Against Lung Cancer is

dedicated to funding innovative research that enables patients,

smokers and non-smokers alike, to win their battles with lung cancer

and live healthy, cancer-free lives years after diagnosis. UALC and

its Partners across the country raise awareness and critical funds for

lung cancer research. For more information, please visit


Contact: Uniting Against Lung Cancer

Holli Kawadler - 212-627-5500


Great Ink Communications

Roxanne Donovan- 212-741-2977


Read more news from Uniting Against Lung Cancer.

SOURCE Uniting Against Lung Cancer

-0- 04/25/2014

/Web Site: http://www.unitingagainstlungcancer.org

CO: Uniting Against Lung Cancer

ST: New York




-- PH12668 --

0000 04/25/2014 12:35:00 EDT http://www.prnewswire.com

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

The Associated Press

KSL Weather Forecast

Updated: Tuesday August 21, 2018 7:13 am